Day One Biopharmaceuticals, Inc.
Biotechnology · Healthcare
Samuel Blackman
Equibles does not estimate personal net worth.
About Samuel Blackman
Day One Biopharmaceuticals, Inc. reported in an 8-K filed May 1, 2023 that Samuel Blackman was appointed Head of Research and Development, effective May 1, 2023. The proxy statement of Day One Biopharmaceuticals, Inc. reports total compensation of $3,614,904 for Samuel Blackman in fiscal 2024, including a base salary of $527,000. Disclosed compensation is on record for 5 fiscal years.
“On May 1, 2023, the Company announced the appointment of Dr. Samuel Blackman, the Company's Co-founder and current Chief Medical Officer, to the position of Head of Research and Development of the Company, effective as of May 1, 2023.”
Affiliation history
-
Day One Biopharmaceuticals, Inc.
Proxy statement
Start not stated–2024-04-05
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Day One Biopharmaceuticals, Inc. | Co-Founder and Head of Research and Development | $527,000 | $3,614,904 |
| 2023 | Day One Biopharmaceuticals, Inc. | Co-Founder and Head of Research and Development | $500,000 | $2,485,392 |
| 2022 | Day One Biopharmaceuticals, Inc. | Co-Founder and Head of Research and Development | $470,000 | $2,077,197 |
| 2021 | Day One Biopharmaceuticals, Inc. | Co-Founder and Head of Research and Development | $422,568 | $2,935,890 |
| 2020 | Day One Biopharmaceuticals, Inc. | Co-Founder and Chief Medical Officer | $367,000 | $477,100 |